CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules

CVS unit must pay $290 million in drug whistleblower lawsuit, judge rulesSource: Reuters
أخبار الاستثمار والأسواق المالية من موقع Investing.com

CVS unit must pay $290 million in drug whistleblower lawsuit, judge rulesSource: Reuters

Rocket Pharma's shares soar after US FDA lets gene therapy trial resumeSource: Reuters

Robotics startup FieldAI raises $314 million in new funding, sources saySource: Reuters

CSI 300 could rally further despite testing 10-year highs: Morgan StanleySource: Investing.com

Factbox-Healthcare firms see growing activist investor involvement in the past yearSource: Reuters

JP Morgan raises Upstart, cuts CompoSecure, Riskified on shifting fintech outloSource: Investing.com

Staff shortages at India's aviation regulator and air traffic control threaten safety, lawmakers saySource: Reuters
Avis Budget double-downgraded: 'Fundamentals don’t support valuation'Source: Investing.com

Guess agrees to $1.4 billion take-private dealSource: Reuters
What happens if JPM buys Apple Card from GoldmanSource: Investing.com